These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1350488

  • 21. Antihypertensive drugs interacting with alpha- and beta-adrenoceptors. A review of basic pharmacology.
    van Zwieten PA.
    Drugs; 1988; 35 Suppl 6():6-19. PubMed ID: 2841084
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 24. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection.
    Feuerstein GZ, Ruffolo RR.
    Eur Heart J; 1995 Jul 26; 16 Suppl F():38-42. PubMed ID: 8521883
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.
    van Zwieten PA, Blauw GJ, van Brummelen P.
    Drugs; 1990 Jul 26; 40 Suppl 4():1-8; discussion 28-30. PubMed ID: 1982649
    [Abstract] [Full Text] [Related]

  • 27. Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension.
    Sica DA.
    J Clin Hypertens (Greenwich); 2005 Jan 26; 7(1):59-64. PubMed ID: 15655391
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacological profile of beta-adrenoceptor blockers with vasodilating properties, especially carvedilol--rationale for clinical use.
    Sponer G, Bartsch W, Strein K.
    Clin Investig; 1992 Jan 26; 70 Suppl 1():S20-6. PubMed ID: 1350480
    [Abstract] [Full Text] [Related]

  • 29. Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential.
    Cheng J, Kamiya K, Kodama I.
    Cardiovasc Drug Rev; 2001 Jan 26; 19(2):152-71. PubMed ID: 11484068
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical experience with dual-acting drugs in hypertension.
    Rahn KH.
    Clin Investig; 1992 Jan 26; 70 Suppl 1():S39-42. PubMed ID: 1350483
    [Abstract] [Full Text] [Related]

  • 34. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM.
    Clin Nephrol; 1995 Jan 26; 43(1):47-52. PubMed ID: 7697935
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    Langer SZ, Cavero I, Massingham R.
    Hypertension; 1980 Jan 26; 2(4):372-82. PubMed ID: 6105128
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.
    Weber K, Bohmeke T, van der Does R, Taylor SH.
    Cardiovasc Drugs Ther; 1996 May 26; 10(2):113-7. PubMed ID: 8842502
    [Abstract] [Full Text] [Related]

  • 38. Carvedilol.
    Frishman WH.
    N Engl J Med; 1998 Dec 10; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract] [Full Text] [Related]

  • 39. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    McTavish D, Campoli-Richards D, Sorkin EM.
    Drugs; 1993 Feb 10; 45(2):232-58. PubMed ID: 7681374
    [Abstract] [Full Text] [Related]

  • 40. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
    Feuerstein GZ, Ruffolo RR.
    Eur Heart J; 1996 Apr 10; 17 Suppl B():24-9. PubMed ID: 8733068
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.